{"id":"https://openalex.org/W1981018944","doi":"https://doi.org/10.1097/jcp.0b013e31825d380d","title":"Human Abuse Potential and Cognitive Effects of Taranabant, a Cannabinoid 1 Receptor Inverse Agonist: A Randomized, Double-Blind, Placebo- and Active-Controlled, Crossover Study in Recreational Polydrug Users","display_name":"Human Abuse Potential and Cognitive Effects of Taranabant, a Cannabinoid 1 Receptor Inverse Agonist: A Randomized, Double-Blind, Placebo- and Active-Controlled, Crossover Study in Recreational Polydrug Users","publication_year":2012,"publication_date":"2012-06-20","ids":{"openalex":"https://openalex.org/W1981018944","doi":"https://doi.org/10.1097/jcp.0b013e31825d380d","mag":"1981018944","pmid":"https://pubmed.ncbi.nlm.nih.gov/22722508"},"language":"en","primary_location":{"id":"doi:10.1097/jcp.0b013e31825d380d","doi":"https://doi.org/10.1097/jcp.0b013e31825d380d","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0b013e31825d380d","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112007410","display_name":"Kerri A. Schoedel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kerri A. Schoedel","raw_affiliation_strings":["INC Research, Toronto, Ontario, Canada. Kerri.Schoedel@incresearch.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INC Research, Toronto, Ontario, Canada. Kerri.Schoedel@incresearch.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089852008","display_name":"Carol Addy","orcid":"https://orcid.org/0000-0003-1028-2649","observed_orcids":["https://orcid.org/0000-0003-1028-2649"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Addy","raw_affiliation_strings":["Merck & Co., Inc., Whitehouse Station"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Whitehouse Station","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072909619","display_name":"Bijan Chakraborty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Bijan Chakraborty","raw_affiliation_strings":["INC Research (formerly Kendle Early Stage-Toronto), Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INC Research (formerly Kendle Early Stage-Toronto), Toronto, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063859878","display_name":"Kim Rosko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim Rosko","raw_affiliation_strings":["Merck & Co., Inc., Whitehouse Station"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Whitehouse Station","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028777703","display_name":"Stephanie A. Dunbar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Dunbar","raw_affiliation_strings":["Merck & Co., Inc., Whitehouse Station"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Whitehouse Station","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105700952","display_name":"Andrea L. Maes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Maes","raw_affiliation_strings":["Merck & Co., Inc., Whitehouse Station","Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Whitehouse Station","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101413431","display_name":"Nancy Chen","orcid":"https://orcid.org/0000-0002-7649-2246","observed_orcids":["https://orcid.org/0000-0002-7649-2246"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nancy Chen","raw_affiliation_strings":["INC Research (formerly Kendle Early Stage-Toronto), Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INC Research (formerly Kendle Early Stage-Toronto), Toronto, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011021512","display_name":"Selwyn Aubrey Stoch","orcid":"https://orcid.org/0000-0001-5620-7092","observed_orcids":["https://orcid.org/0000-0001-5620-7092"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Selwyn Aubrey Stoch","raw_affiliation_strings":["Merck & Co., Inc., Whitehouse Station"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Whitehouse Station","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111938300","display_name":"John A. Wagner","orcid":"https://orcid.org/0000-0002-0636-5006","observed_orcids":["https://orcid.org/0000-0002-0636-5006","https://orcid.org/0000-0003-0038-8511"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Wagner","raw_affiliation_strings":["Merck & Co., Inc., Whitehouse Station"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Whitehouse Station","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112025856","display_name":"J Chodakewitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff Chodakewitz","raw_affiliation_strings":["Merck & Co., Inc., Whitehouse Station"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Whitehouse Station","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013791504","display_name":"Edward M. Sellers","orcid":"https://orcid.org/0000-0002-0669-2373","observed_orcids":["https://orcid.org/0000-0002-0669-2373"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Edward M. Sellers","raw_affiliation_strings":["Departments of Pharmacology, Medicine and Psychiatry, University of Toronto, Toronto, Ontario, Canada","INC Research (formerly Kendle Early Stage-Toronto), Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology, Medicine and Psychiatry, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"INC Research (formerly Kendle Early Stage-Toronto), Toronto, Ontario, Canada","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5013791504","https://openalex.org/A5072909619","https://openalex.org/A5101413431","https://openalex.org/A5112007410"],"corresponding_institution_ids":["https://openalex.org/I185261750"],"apc_list":null,"apc_paid":null,"fwci":1.0775,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.74596399,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":"4","first_page":"492","last_page":"502"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.9470000267028809},{"id":"https://openalex.org/keywords/cognitive-effects","display_name":"cognitive effects","score":0.7110000252723694},{"id":"https://openalex.org/keywords/phentermine","display_name":"phentermine","score":0.9589999914169312},{"id":"https://openalex.org/keywords/dronabinol","display_name":"dronabinol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/subjective-drug-effects","display_name":"subjective drug effects","score":0.8289999961853027},{"id":"https://openalex.org/keywords/motor-performance","display_name":"motor performance","score":0.5199999809265137},{"id":"https://openalex.org/keywords/obesity-treatment","display_name":"obesity treatment","score":0.5130000114440918},{"id":"https://openalex.org/keywords/recreational-drug-use","display_name":"recreational drug use","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C89951826","wikidata":"https://www.wikidata.org/wiki/Q1671731","display_name":"Inverse agonist","level":4,"score":0.9301532506942749},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6393130421638489},{"id":"https://openalex.org/C2780871563","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid","level":3,"score":0.6045758724212646},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.5652863383293152},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44130030274391174},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40178385376930237},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3628550171852112},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3177083730697632},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3105667531490326},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1978638470172882}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002189","descriptor_name":"Marijuana Abuse","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D010645","descriptor_name":"Phentermine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011674","descriptor_name":"Pulse","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013759","descriptor_name":"Dronabinol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D054314","descriptor_name":"Drug Inverse Agonism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055030","descriptor_name":"Drug Users","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/jcp.0b013e31825d380d","doi":"https://doi.org/10.1097/jcp.0b013e31825d380d","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0b013e31825d380d","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:22722508","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22722508","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W54728729","https://openalex.org/W127670622","https://openalex.org/W1965248019","https://openalex.org/W1966513857","https://openalex.org/W1970733771","https://openalex.org/W1972911528","https://openalex.org/W1975655569","https://openalex.org/W1976511549","https://openalex.org/W1981147834","https://openalex.org/W1983875437","https://openalex.org/W1987802056","https://openalex.org/W1991694489","https://openalex.org/W1997756918","https://openalex.org/W1998101912","https://openalex.org/W2002066221","https://openalex.org/W2006701767","https://openalex.org/W2016753139","https://openalex.org/W2024221433","https://openalex.org/W2028901928","https://openalex.org/W2029535535","https://openalex.org/W2033748464","https://openalex.org/W2036806118","https://openalex.org/W2039978408","https://openalex.org/W2046707923","https://openalex.org/W2047029495","https://openalex.org/W2050246666","https://openalex.org/W2050335444","https://openalex.org/W2052080148","https://openalex.org/W2053586784","https://openalex.org/W2060475215","https://openalex.org/W2061540970","https://openalex.org/W2071538269","https://openalex.org/W2082427099","https://openalex.org/W2091638846","https://openalex.org/W2092554151","https://openalex.org/W2093249675","https://openalex.org/W2094545875","https://openalex.org/W2106654511","https://openalex.org/W2110065044","https://openalex.org/W2132322340","https://openalex.org/W2140215853","https://openalex.org/W2147501423","https://openalex.org/W2165284792","https://openalex.org/W2168467010","https://openalex.org/W2320648003"],"related_works":["https://openalex.org/W1983875437","https://openalex.org/W2147501423","https://openalex.org/W2251542336","https://openalex.org/W2140215853","https://openalex.org/W2106499597","https://openalex.org/W2895399537","https://openalex.org/W2576368253","https://openalex.org/W1991076419","https://openalex.org/W2124276340","https://openalex.org/W2065375127"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Taranabant":[1,137,212],"is":[2],"a":[3,59,100],"cannabinoid":[4,228],"1":[5,229],"receptor":[6,230],"inverse":[7,231],"agonist":[8],"that":[9,227],"was":[10,25,138],"in":[11,37,58,222],"development":[12],"for":[13,88],"treatment":[14],"of":[15,18,35,146,209],"obesity.":[16],"Because":[17],"central":[19],"nervous":[20],"system":[21],"effects,":[22,125],"the":[23,29,147,155,205,210],"study":[24,62],"performed":[26],"to":[27,63,166,235],"assess":[28],"abuse":[30,220],"potential":[31,221],"and":[32,45,49,69,74,80,83,91,107,122,134,158,168,177,188,201,207],"cognitive":[33],"effects":[34,96,113,153,160,194,218],"taranabant":[36,65,186],"recreational":[38,223],"polydrug":[39,51,224],"users":[40,52],"compared":[41],"with":[42],"phentermine,":[43],"dronabinol,":[44],"placebo.":[46,81],"METHODS:":[47],"Stimulant-":[48],"cannabis-experienced":[50],"(N":[53],"=":[54],"30)":[55],"were":[56,86,97,161],"randomized":[57],"double-blind":[60],"crossover":[61],"receive":[64],"2,":[66],"4,":[67],"10,":[68],"20":[70,78,128,189],"mg;":[71,76,79],"phentermine":[72,167,200],"45":[73,106],"90":[75,108],"dronabinol":[77,127,169,178,202],"Subjective":[82],"neurocognitive":[84],"measures":[85,149],"administered":[87],"24":[89],"hours,":[90],"peak/peak":[92],"change":[93],"from":[94,142],"baseline":[95],"analyzed":[98],"using":[99],"linear":[101],"mixed-effects":[102],"model.":[103],"RESULTS:":[104],"Phentermine":[105,173],"mg":[109,129,190],"showed":[110,130],"abuse-related":[111,131],"subjective":[112,148],"versus":[114],"placebo,":[115],"including":[116],"drug":[117,120],"liking,":[118,121],"overall":[119],"other":[123,150],"positive/stimulant":[124],"whereas":[126,185],"positive,":[132],"cannabis-like,":[133],"sedative":[135],"effects.":[136],"not":[139,214],"significantly":[140,162],"different":[141],"placebo":[143],"on":[144,170,182,195],"most":[145,171],"than":[151],"negative/dysphoric":[152],"at":[154],"highest":[156],"dose,":[157],"its":[159],"less":[163],"pronounced":[164],"relative":[165],"measures.":[172],"improved":[174],"cognitive/motor":[175],"performance":[176,181],"impaired":[179],"motor/cognitive":[180],"some":[183],"measures,":[184],"4":[187],"had":[191],"minor":[192],"impairment":[193],"manual":[196],"tracking.":[197],"CONCLUSIONS:":[198],"The":[199],"results":[203],"demonstrate":[204],"validity":[206],"sensitivity":[208],"study.":[211],"did":[213],"consistently":[215],"show":[216],"stimulant/cannabis-like":[217],"or":[219],"users,":[225],"indicating":[226],"agonists/antagonists":[232],"are":[233],"unlikely":[234],"be":[236],"recreationally":[237],"abused.":[238]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}